Veracyte, Inc. (VCYT)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Veracyte, Inc. (VCYT)
Go deeper and ask any question about VCYT
Company Performance
Current Price
as of Sep 13, 2024$32.92
P/E Ratio
N/A
Market Cap
$2.53B
Description
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.
Metrics
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerVCYT
- Price$32.92+8.22%
Trading Information
- Market Cap$2.53B
- Float98.48%
- Average Daily Volume (1m)703,578
- Average Daily Volume (3m)956,546
- EPS-$0.74
Company
- Revenue$399.58M
- Rev Growth (1yr)26.69%
- Net Income$5.73M
- Gross Margin66.23%
- EBITDA Margin9.13%
- EBITDA$10.44M
- EV$1.46B
- EV/Revenue3.65
- P/EN/A
- P/S6.36
Documents
SEC Filings
Earnings Calls
Factset Street Account